2024 ICD-10-CM Diagnosis Code C08.1

Malignant neoplasm of sublingual gland

ICD-10-CM Code:
C08.1
ICD-10 Code for:
Malignant neoplasm of sublingual gland
Is Billable?
Yes - Valid for Submission
Chronic Condition Indicator: [1]
Chronic
Code Navigator:

Code Classification

  • Neoplasms
    (C00–D49)
    • Malignant neoplasms of lip, oral cavity and pharynx
      (C00-C14)
      • Malignant neoplasm of other and unspecified major salivary glands
        (C08)

C08.1 is a billable diagnosis code used to specify a medical diagnosis of malignant neoplasm of sublingual gland. The code is valid during the current fiscal year for the submission of HIPAA-covered transactions from October 01, 2023 through September 30, 2024.

The following anatomical sites found in the Table of Neoplasms reference this diagnosis code given the correct histological behavior: Neoplasm, neoplastic salivary gland or duct (major) sublingual or Neoplasm, neoplastic sublingual gland or duct .

Approximate Synonyms

The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:

  • Carcinoma of sublingual gland
  • Malignant tumor of sublingual gland
  • Primary adenocarcinoma of sublingual gland
  • Primary carcinoma of sublingual gland
  • Primary malignant neoplasm of sublingual gland
  • Primary squamous cell carcinoma of sublingual gland

Clinical Classification

Convert C08.1 to ICD-9-CM

  • ICD-9-CM Code: 142.2 - Malig neo sublingual

Table of Neoplasms

This code is referenced in the table of neoplasms by anatomical site. For each site there are six possible code numbers according to whether the neoplasm in question is malignant, benign, in situ, of uncertain behavior, or of unspecified nature. The description of the neoplasm will often indicate which of the six columns is appropriate.

Where such descriptors are not present, the remainder of the Index should be consulted where guidance is given to the appropriate column for each morphological (histological) variety listed. However, the guidance in the Index can be overridden if one of the descriptors mentioned above is present.

Neoplasm, neoplastic Malignant
Primary
Malignant
Secondary
CaInSitu Benign Uncertain
Behavior
Unspecified
Behavior
»Neoplasm, neoplastic
  »salivary gland or duct (major)
    »sublingual
C08.1C79.89D00.00D11.7D37.031D49.0
»Neoplasm, neoplastic
  »sublingual
    »gland or duct
C08.1C79.89D00.00D11.7D37.031D49.0

Patient Education


Salivary Gland Cancer

Your salivary glands make saliva - sometimes called spit - and empty it into your mouth through openings called ducts. Saliva makes your food moist, which helps you chew and swallow. It helps you digest your food. It also cleans your mouth and contains antibodies that can kill germs.

Salivary gland cancer is a type of head and neck cancer. It is rare. It may not cause any symptoms, or you could notice:

  • A lump in your ear, cheek, jaw, lip, or inside the mouth
  • Fluid draining from your ear
  • Trouble swallowing or opening the mouth widely
  • Numbness, weakness, or pain in your face

Doctors diagnose salivary gland cancer using a physical exam, imaging tests, and a biopsy. Treatment can include surgery, radiation therapy, and/or chemotherapy.

NIH: National Cancer Institute


[Learn More in MedlinePlus]

Code History

  • FY 2024 - No Change, effective from 10/1/2023 through 9/30/2024
  • FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
  • FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022
  • FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
  • FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
  • FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
  • FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016. This was the first year ICD-10-CM was implemented into the HIPAA code set.

Footnotes

[1] Chronic - a chronic condition code indicates a condition lasting 12 months or longer and its effect on the patient based on one or both of the following criteria:

  • The condition results in the need for ongoing intervention with medical products,treatment, services, and special equipment
  • The condition places limitations on self-care, independent living, and social interactions.